Physician profile
Robert S Wolff
NPI 1477558195
$11,604.84
in general payments reported to CMS, 2019-2025
25 companies · $819 in 2025
The $819 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,834 · 2020: $621 · 2021: $3,719 · 2022: $1,856 · 2023: $1,163 · 2024: $1,594 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,550 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,549.94 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Cataract Technology INC. | $3,276.40 | 2021-2022 | |
| Alcon Vision LLC | $2,280.64 | 2019-2025 | Clareon |
| Glaukos Corporation | $1,710.47 | 2020-2025 | Idose, Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| New World Medical,INC. | $924.90 | 2020-2025 | Clearpath, Streamline, Kahook Dual Blade |
| Rxsight INC | $621.62 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $490.58 | 2019-2023 | Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $408.63 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $379.12 | 2022-2023 | Lotemax Sm |
| Ivantis, INC | $242.91 | 2019 | |
| Sight Sciences, INC. | $234.79 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $189.68 | 2019-2023 | |
| Abbvie INC. | $180.59 | 2022-2024 | Durysta, Lumigan, Alphagan P |
| Biotissue Holdings INC. | $113.43 | 2019-2024 | |
| Allergan, INC. | $99.58 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $78.19 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $76.35 | 2019-2024 | Scoutpro Osmolarity System |
| Novartis Pharmaceuticals Corporation | $54.67 | 2021-2022 | |
| Dompe US, INC. | $50.57 | 2022-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $45.08 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $40.51 | 2019 | |
| Eyepoint US, INC. | $39.08 | 2020-2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Mallinckrodt Hospital Products INC. | $17.95 | 2025 | Acthar |
| Omeros Corporation | $15.19 | 2019 | |
| Thea Pharma INC. | $14.51 | 2023 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.